Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis. 2023

Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Background and Objectives: The risk of developing cardiovascular diseases (CVD) in patients suffering from rheumatoid arthritis (RA) is two times higher compared to the general population. The objective of this retrospective study was to determine which cardiovascular complications can appear in men vs. women with rheumatoid arthritis. Early diagnosis and initiation of therapeutic measures to reduce the progression rate of rheumatoid arthritis, while also maintaining an active lifestyle, are the most important problems in young patients. Materials and Methods: We included a number of 200 patients, divided into two groups according to gender (124 women and 76 men) with rheumatoid arthritis, presenting various stages of disease concomitant with cardiovascular complications. We assessed traditional and non-traditional risk factors, as well as electrocardiographic and echocardiographic findings in both groups. Results: All patients presented an atherogenic coefficient over two, indicating a significant risk of atherogenesis. Men had elevated levels of total cholesterol compared with women (≥200 mg/dL; 77.6%-men vs. 25.8%-women, p < 0.001). The participants presented cardiac arrhythmias, especially in the active stage of RA. Women had an increased risk of atrial fibrillation by 2.308 times compared to men (p = 0.020). One of the most important complications found in young women was pulmonary arterial hypertension (p = 0.007). Conclusions: In daily clinical practice, the screening of RA is carried out in sufficiently. This disease is often undiagnosed, and the risk factors remain unassessed. As a result, RA patients continue to present an increased risk of developing CVD.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
April 2019, Zeitschrift fur Rheumatologie,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
September 2017, Rheumatology international,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
January 2014, Reumatizam,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
November 2018, Current rheumatology reports,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
January 2024, Clinical rheumatology,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
December 2017, Rheumatology and therapy,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
November 2013, Annals of the rheumatic diseases,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
November 2017, Arthritis research & therapy,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
July 2023, Clinical and experimental rheumatology,
Marius Rus, and Adriana Ioana Ardelean, and Claudia Judea Pusta, and Simina Crisan, and Paula Marian, and Liliana Oana Pobirci, and Veronica Huplea, and Alina Stanca Osiceanu, and Gheorghe Adrian Osiceanu, and Felicia Liana Andronie-Cioara, and Madalina Ioana Guler
January 2013, Medicina,
Copied contents to your clipboard!